PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
26-Mar-2024 Panthera Biopartners appoints Martyn Jellett as Associate Director Business Development to support growing commercial team Panthera Biopartners
26-Mar-2024 Asceneuron Joins Critical Path for Alzheimer’s Disease Consortium Asceneuron
26-Mar-2024 Research published in Journal of the American Chemical Society highlights potential of HIF Inhibition as a therapeutic approach for cancers Curve Therapeutics
26-Mar-2024 STORM Therapeutics to Present Data on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at AACR Annual Meeting 2024 STORM Therapeutics Ltd
26-Mar-2024 Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team Laverock Therapeutics
26-Mar-2024 Endostart receives FDA 510(k) clearance for Endorail®, ushering in new era of gastrointestinal endoscopy innovation Andrew Lloyd Associates
26-Mar-2024 PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition PharmaBlock
26-Mar-2024 Corteria Pharmaceuticals announces initiation of Phase 1 study to evaluate CRF2 agonist COR-1167 for treatment of worsening heart failure Andrew Lloyd Associates
26-Mar-2024 CD Formulation Incorporates Phase Separation Method for Microsphere Production CD Formulation
25-Mar-2024 Theriva™ Biologics Reports Full-Year 2023 Operational Highlights and Financial Results Theriva™ Biologics, Inc.
25-Mar-2024 DPI, BII and EBRD announce exit from KELIX bio, a leading emerging markets biopharmaceutical platform they created in 2020 DPI
25-Mar-2024 Researchers uncover protein interactions controlling fertility in female mice The Francis Crick Institute
25-Mar-2024 CAS Announces 2024 Selections for Prestigious CAS Future Leaders™ Program CAS
22-Mar-2024 4SC AG provides results for financial year 2023 and outlook for 2024 4SC AG
22-Mar-2024 First patient in the UK is dosed in the OATD-01 Phase 2 KITE study in pulmonary sarcoidosis Molecure S.A.
22-Mar-2024 HUTCHMED Initiates Registration Stage of the ESLIM-02 Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China HUTCHMED
22-Mar-2024 CD Formulation Introduces Microneedle Patch Innovations for Enhanced Drug Delivery Efficiency CD Formulation
20-Mar-2024 New light-activated antimicrobial expands usage across Canada Ondine Biomedical Inc.
20-Mar-2024 Scintil Photonics Andrew Lloyd Associates
20-Mar-2024 CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies CD Formulation